http://www.miha.rs/ 2016-10-03T10:52:23+00:00 monthly 1.0000 http://www.miha.rs/index.html 2016-10-03T10:52:23+00:00 monthly 0.8000 http://www.miha.rs/publications-experience.html 2016-10-03T10:52:23+00:00 monthly 0.8000 http://www.miha.rs/sercices.html 2016-10-03T10:52:23+00:00 monthly 0.8000 http://www.miha.rs/contact.html 2016-10-03T10:52:22+00:00 monthly 0.8000 http://www.miha.rs/publications/Cancer%20incidence%20and%20mortality%20in%20Serbia%201999-2009.pdf 2016-10-03T10:55:24+00:00 monthly 0.6400 http://www.miha.rs/publications/Cost-effectiveness%20and%20budget%20impact%20analysis%20of%20everolimus%20for%20second-line%20treatment%20of%20metastatic%20renal%20cell%20cancer%20in%20Serbia.pdf 2016-10-03T10:55:24+00:00 monthly 0.6400 http://www.miha.rs/publications/Cost%20effectiveness%20of%20cervical%20cancer%20screening%20in%20Serbia.%20A%20comparison%20of%20screening%20policies.pdf 2016-10-03T10:55:24+00:00 monthly 0.6400 http://www.miha.rs/publications/Cost%20utility%20analysis%20of%20everolimus%20in%20the%20treatment%20of%20metastatic%20renal%20cell%20cancer%20in%20the%20Netherlands.ppt 2016-10-03T10:55:24+00:00 monthly 0.6400 http://www.miha.rs/publications/Reimbursement%20of%20Targeted%20Cancer%20Therapies%20Within%203%20Different%20European%20Health%20Care%20Systems.pdf 2016-10-03T10:55:24+00:00 monthly 0.6400 http://www.miha.rs/publications/Network%20meta-analysis%20of%20overall%20and%20progression%20free%20survival%20of%20first%20line%20metastatic%20renal%20cell%20targeted%20therapies.pdf 2016-10-03T10:55:24+00:00 monthly 0.6400 http://www.miha.rs/publications/Micro-costing%20study%20of%20rituximab%20subcutaneous%20injection%20versus%20intravenous%20infusion.pptx 2016-10-03T10:55:24+00:00 monthly 0.6400